Literature DB >> 24875597

Facile solid phase peptide synthesis with a Re-lysine conjugate generated via a one-pot procedure.

Kullapa Chanawanno1, Joel Caporoso, Vinay Kondeti, Sailaja Paruchuri, Thomas C Leeper, Richard S Herrick, Christopher J Ziegler.   

Abstract

We have synthesized a Re(CO)3-modified lysine via a one-pot Schiff base formation reaction that can be used in the solid phase peptide synthesis. To demonstrate its potential use, we have attached it to a neurotensin fragment and observed uptake into human umbilical vascular endothelial cells.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24875597      PMCID： PMC4991030          DOI： 10.1039/c4dt01129e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN： 1477-9226            Impact factor:   4.390


  21 in total

Review 1.  Current use and future potential of organometallic radiopharmaceuticals.

Authors:  Roger Schibli; P August Schubiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-08-06       Impact factor: 9.236

Review 2.  The role of coordination chemistry in the development of target-specific radiopharmaceuticals.

Authors:  Shuang Liu
Journal:  Chem Soc Rev       Date:  2004-08-16       Impact factor: 54.564

Review 3.  Interactions between neurotensin receptors and G proteins.

Authors:  Didier Pelaprat
Journal:  Peptides       Date:  2006-08-17       Impact factor: 3.750

4.  Synthesis of dimeric Re(I) amino acid conjugate complexes.

Authors:  Hira Qayyum; Richard S Herrick; Christopher J Ziegler
Journal:  Dalton Trans       Date:  2011-06-21       Impact factor: 4.390

Review 5.  Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis.

Authors:  Ho-Jin Park; Yali Zhang; Serban P Georgescu; Kristin L Johnson; Dequon Kong; Jonas B Galper
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 6.  Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.

Authors:  Mark Bartholomä; John Valliant; Kevin P Maresca; John Babich; Jon Zubieta
Journal:  Chem Commun (Camb)       Date:  2008-12-01       Impact factor: 6.222

7.  Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.

Authors:  Faisal Alshoukr; Cedric Rosant; Veronique Maes; Jallane Abdelhak; Olivier Raguin; Samuel Burg; Laure Sarda; Jacques Barbet; Dirk Tourwé; Didier Pelaprat; Anne Gruaz-Guyon
Journal:  Bioconjug Chem       Date:  2009-07-17       Impact factor: 4.774

8.  Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes.

Authors:  Anna Leonidova; Vanessa Pierroz; Riccardo Rubbiani; Jakob Heier; Stefano Ferrari; Gilles Gasser
Journal:  Dalton Trans       Date:  2014-03-21       Impact factor: 4.390

9.  The synthesis of biologically relevant conjugates of Re(CO)3 using pyridine-2-carboxyaldehyde.

Authors:  Roshinee Costa; Kullapa Chanawanno; James T Engle; Bertha Baroody; Richard S Herrick; Christopher J Ziegler
Journal:  J Organomet Chem       Date:  2013-06-15       Impact factor: 2.369

Review 10.  Click-to-Chelate: development of technetium and rhenium-tricarbonyl labeled radiopharmaceuticals.

Authors:  Christiane A Kluba; Thomas L Mindt
Journal:  Molecules       Date:  2013-03-12       Impact factor: 4.411
View more
  2 in total

1.  Using Hydrazine to Link Ferrocene with Re(CO)3: A Modular Approach.

Authors:  Kullapa Chanawanno; Hannah M Rhoda; Abed Hasheminasab; Laura A Crandall; Alexander J King; Richard S Herrick; Victor N Nemykin; Christopher J Ziegler
Journal:  J Organomet Chem       Date:  2016-06-07       Impact factor: 2.369

2.  Facile rhenium-peptide conjugate synthesis using a one-pot derived Re(CO)3 reagent.

Authors:  Kullapa Chanawanno; Vinay Kondeti; Joel Caporoso; Sailaja Paruchuri; Thomas C Leeper; Richard S Herrick; Christopher J Ziegler
Journal:  Dalton Trans       Date:  2016-02-10       Impact factor: 4.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.